We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ana Hldgs | LSE:ANA | London | Ordinary Share | JP3429800000 | Y50 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 301.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
ANANDA DEVELOPMENTS PLC
("Ananda" or the "Company")
Investor Evening
Ananda Developments plc (AQSE: ANA), a company focused on becoming a leading provider of regulator approved CBD-based medicines for chronic inflammatory pain conditions, is pleased to announce its participation in "The Pub Test" Investor Evening. This event is co-hosted by the Aquis Exchange and InvestorHub and will take place on Wednesday, 17th July 2024 at Samuel Pepys, Stew Ln, London EC4V 3PT, starting at 6:00 PM.
The Company's CEO, Melissa Sturgess, will engage in a fireside conversation designed especially for private investors. This setting offers a unique opportunity for attendees to interact directly with company executives, ask questions, and network with fellow investors.
Ananda's CEO, Melissa Sturgess, commented: "We look forward to meeting and engaging with interested parties, shareholders, potential shareholders, and stakeholders. This event is a fantastic opportunity to share our vision and answer any questions investors may have."
All attendees will have the chance to network over drinks and a buffet.
To register for the event, please use the following link: https://events.humanitix.com/the-pub-test-or-london-july-4-2024
For more information please contact:
InvestorHub Engage with us directly at Ananda Developments Investor Hub
|
Sign up at |
ANANDA DEVELOPMENTS PLC Chief Executive Officer Melissa Sturgess Executive Director Jeremy Sturgess-Smith
|
+44 (0)7463 686 497 ir@anandadevelopments.com |
SP ANGEL CORPORATE FINANCE LLP Corporate Finance Richard Morrison Caroline Rowe
|
+44 (0)20 3470 0470 |
Corporate Broking Abigail Wayne Rob Rees
|
|
Yellow Jersey PR Charles Goodwin Zara McKinlay |
+44 (0)20 3004 9512 |
About Ananda Developments
Ananda is an AQSE-listed company whose ambition is to be a leading provider of cannabinoid-based medicines for the treatment of complex, chronic inflammatory pain conditions.
For further information on the Company visit https://anandadevelopments.com/ or sign up at
https://investors.anandadevelopments.com/s/a66906.
https://investors.anandadevelopments.com/link/8r6koP
END
1 Year Ana Hldgs Chart |
1 Month Ana Hldgs Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions